Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
BioMarin Pharmaceutical of Novato, California, will...
BioMarin Pharma will pay up to $96 million to acquire...
Shanghai Pharma will acquire a 65% stake in China Health...
Catalent Pharma Solutions, a New Jersey company,...
Catalent Pharma Solutions of the US has opened a Clinical...
Chindex, which operates private hospitals and clinics in...
Wuxi AppTec, China's largest CRO/CMO, began the...
WuXi Biologics priced its Hong Kong IPO at the top of the...
ShangPharma will merge its Shanghai...
Deals and Financings
BGI Genomics, the...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
